CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +951 | $9.13 | $9K | 37,115 |
| 2026-05-05 | Fuhrman Alan Chief Financial Officer | Grant or award | +20,000 | 36,164 | ||
| 2026-05-05 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +67,000 | 67,000 | ||
| 2026-03-13 | Fuhrman Alan Chief Financial Officer | Grant or award | +1,376 | $9.13 | $13K | 16,164 |
| 2025-09-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +701 | $9.13 | $6K | 14,788 |
| 2025-08-07 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2025-03-14 | Fuhrman Alan Chief Financial Officer | Grant or award | +1,238 | $9.78 | $12K | 14,087 |
| 2024-10-30 | Fuhrman Alan Chief Financial Officer | Purchase | +9,500 | $16.00 | $152K | 12,849 |
| 2024-09-13 | Fuhrman Alan Chief Financial Officer | Grant or award | +954 | $12.48 | $12K | 3,349 |
| 2024-08-14 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-03-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +932 | $12.48 | $12K | 2,395 |
| 2023-09-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +1,463 | $12.50 | $18K | 1,463 |
| 2023-07-28 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +62,685 | 62,685 | ||
| 2023-01-01 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +32,800 | 32,800 | ||
| 2023-01-01 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +328,000 | 328,000 |
Page 1 of 1 · 15 trades